Articles

The designation of END products as “tobacco products” rather than “medical products” in August 2016 meant manufacturers did not have to meet pharmaceutical safety standards; instead, minimal product safety regulations were imposed.

The COVID-19 pandemic is adversely affecting efforts to control substance abuse according to Assistant Secretary of Health Admiral Brett P. Giroir, MD, who spoke with Rosalie Liccardo Pacula and Adam Leventhal.

Ritika Chaturvedi will lead the American Life in Real-time (ALiR) project, which will use digital technologies to create precision public health interventions that focus on reducing health disparities.

As the coronavirus pandemic continues, parents put off or cancel their kids’ health appointments.

To protect Californians from rising health care costs, the state needs to strengthen price transparency and price competition, according to Melnick.

What changes should be made now to the U.S. healthcare system to make it better when things return to a new normal, and, in the event of future pandemics.

While many experts believe biosimilars have the potential to lower drug costs through competitive pressure, adoption has been slower than some expected.

Deaton and Case discussed healthcare trends in the context of their latest book, Deaths of Despair and the Future of American Capitalism, during a Schaeffer Center webinar.

Virtual Dental Home provided low-income parents access to dental care for their kids at schools, providing early prevention, treatment and oral health guidance. The coronavirus shut down this essential service.

Treatment for COVID-19 would deliver up to $106 billion in gains by the end of 2021 a new USC Schaeffer Center analysis finds.